Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) Peptid
Kurzübersicht für Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) Peptid (ABIN8112771)
Target
Quelle
Applikation
-
-
Verwendungszweck
- SART3 Peptide
-
-
Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) peptide
SART3 Reaktivität: Human Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-SART3 antibody ( ARP39128_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
-
Hintergrund
-
Background Information: SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing.
Alternative Symbols: P100, p110, DSAP1, TIP110, p110(nrb), RP11-13G14
-
Molekulargewicht
- 40kDa
-
Gen-ID
- 9733
-
UniProt
- Q15020
Target
-
